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Leinamycin Biosynthesis Revealing Unprecedented
Architectural Complexity for a Hybrid Polyketide
Synthase and Nonribosomal Peptide Synthetase
is mediated by an episulfonium ion intermediate [6, 9,
10]. The latter mechanism represents an unprecedented
mode of action for the thiol-dependent DNA cleavage
by LNM.
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Madison, Wisconsin 53705 activities, and novel mode of action have spurred great
interest in developing LNM into a clinically useful anti-
cancer drug [10–12]. Total synthesis of LNM has been
accomplished [13, 14], and chemical modification [11,Summary
12, 15] and functional mimics [10, 16–18] of the natural
LNM have been extensively investigated. These studiesA 135,638 bp DNA region that encompasses the leina-
mycin (LNM) biosynthetic gene cluster was sequenced generated a number of LNM analogs with improved anti-
tumor activity, supporting the wisdom of making novelfrom Streptomyces atroolivaceus S-140. The bound-
aries of the lnm cluster were defined by systematic anticancer drugs based on the LNM molecular scaffold.
Complementary to making microbial metabolites andinactivation of open reading frames within the se-
quenced region. The lnm cluster spans 61.3 kb of DNA their structural analogs by chemical synthesis, “combi-
natorial biosynthesis,” the generation of novel analogsand consists of 27 genes encoding nonribosomal pep-
tide synthetase (NRPS), polyketide synthase (PKS), hy- of natural products by genetic engineering of biosyn-
thetic pathways, offers a promising alternative thatbrid NRPS-PKS, resistance, regulatory, and tailoring
enzymes, as well as proteins of unknown function. A would allow the preparation of these compounds bio-
synthetically [19–22]. The success of this approach de-model for LNM biosynthesis is proposed, central to
which is the LNM hybrid NRPS-PKS megasynthetase pends critically on (1) the development of novel methods
and strategies for combinatorial manipulation of naturalconsisting of discrete (LnmQ and LnmP) and modular
(LnmI) NRPS, acyltransferase-less PKS (LnmG, LnmI, product biosynthetic gene clusters and (2) the continu-
ous discovery and characterization of novel biosyntheticand LnmJ), and PKS modules with unusual domain
organization. These studies unveil an unprecedented machinery that can be utilized for combinatorial biosyn-
thesis. Given its unprecedented molecular architecturearchitectural complexity for the LNM hybrid NRPS-
PKS megasynthetase and set the stage to investigate and potent antitumor activity, LNM offers a distinct op-
portunity to discover new chemistry for natural productthe molecular basis for LNM biosynthesis.
biosynthesis and to develop new strategies and meth-
ods for combinatorial biosynthesis.Introduction
Recently, we reported the identification and localiza-
tion of the LNM biosynthetic gene cluster from S. atrooli-Leinamycin (LNM) is a novel antitumor antibiotic pro-
duced by several Streptomyces atroolivaceus species vaceus S-140 [23]. Dissection of the biosynthetic path-
way revealed a new type of polyketide synthase (PKS),[1–3]. It is structurally characterized by an unusual 1,3-
dioxo-1,2-dithiolane moiety that is spiro-fused to an 18- which we named “acyltransferase (AT)-less PKS,” in
which the cognate AT domain is absent from all PKSmembered macrolactam ring of hybrid peptide-polyke-
tide origin, a molecular architecture that has not been modules and the AT activity is instead provided in trans
by a discrete protein [24]. Here, we describe the se-found to date in any other natural product (Figure 1).
LNM exhibits a broad spectrum of antimicrobial activity quence of the complete LNM biosynthetic gene cluster,
determination of the cluster boundaries, and functionalagainst both gram-positive and gram-negative bacteria
and shows potent antitumor activity in murine tumor assignments of gene products and propose, on the ba-
sis of these results, a model for the LNM biosyntheticmodels in vivo. Most significantly, it is active against
pathway. Our studies unveiled an unprecedented archi-tumors that are resistant to clinically important antican-
tectural complexity for the LNM hybrid NRPS-PKScer drugs, such as cisplatin, doxorubicin, mitomycin,
megasynthetase, consisting of discrete and modularand cyclophosphamide [2, 3]. LNM preferentially inhibits
NRPSs, an AT-less modular PKS that requires a discrete,DNA synthesis and interacts directly with DNA to cause
iteratively acting AT, and PKS modules with unusualsingle-strand scission of DNA in the presence of thiol
domain organization. These findings set the stage toagents as cofactors [4–8]. The presence of the sulfoxide
investigate the molecular basis for LNM biosynthesisgroup in the dithiolane moiety is essential for the DNA-
and to apply combinatorial biosynthesis methods to thecleaving activity. Simple 1,3-dioxo-1,2-dithiolanes are
LNM biosynthetic machinery to generate structural di-also thio-dependent DNA cleaving agents in vitro [9, 10].
versity for anticancer drug discovery.But the mechanisms for DNA cleavage by simple 1,3-
dioxo-1,2-dithiolanes and LNM are distinct. Oxidative
Resultscleavage by 1,3-dioxo-1,2-dithiolanes converts molecu-
lar oxygen to DNA-cleaving oxygen radicals and is medi-
Sequence Analysis of the lnmated by polysulfides, while alkylative cleavage by LNM
Biosynthetic Gene Cluster
Shotgun DNA sequencing of the previously identified*Correspondence: bshen@pharmacy.wisc.edu
3 These authors contributed equally to this work. lnm biosynthetic locus [23] yielded 135,638 bp of contig-
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Figure 1. Proposed Model for LNM Biosynthesis and Modular Organization of the LNM Hybrid NRPS-PKS Megasynthetase with the Discrete
LnmG AT Enzyme Loading the Malonyl CoA Extender Units to All Six PKS Modules
The structures in brackets are hypothetical. Color coding indicates the moiety of LNM that is of peptide (blue), polyketide (red), and other
(black) origin. ACP, PCP, and AT and its proposed docking domains are shaded in red, blue, and green, respectively, to highlight the assembly-
line mechanism for LNM biosynthesis. A green oval denotes an AT docking domain, and a question mark denotes a domain of unknown
function. A, adenylation; ACP, acyl carrier protein; AT, acyltransferase; Cy, condensation/cyclization; DH, dehydratase; KR, ketoreductase;
KS, ketosynthase; MT, methyltransferase; Ox, oxidation; TE, thioesterase.
uous DNA sequence, the overall GC content of which and Table 1). Among them, 14 are biosynthetic genes
encoding NRPSs (lnmP and lnmQ), PKSs (lnmG, lnmJ,is 72.4%, characteristic of Streptomyces DNA [25]. Bio-
informatic analysis of the sequenced region revealed lnmL, and lnmM), hybrid NRPS/PKS (lnmI), and other
tailoring enzymes (lnmA, lnmB, lnmD, lnmF, lnmN,72 open reading frames (ORFs) (Figure 2). Functional
assignments to individual ORFs were made by compar- lnmW, and lnmZ), one is a regulatory gene (lnmO), five
are resistance genes (lnmR, lnmS, lnmT, lnmU, anding the deduced gene products with proteins of known
functions in the database and are summarized in Table lnmY) and the remaining seven (lnmC, lnmE, lnmH,
lnmK, lnmV, lnmX, and lnmZ) are genes whose func-1 (only those within the lnm cluster). The GenBank ac-
cession number for this cluster is AF484556 (the entire tions could not be predicted by sequence comparison
alone.sequenced region).
Determination of the lnm Gene Genes Encoding NRPSs
The lnmQ and lnmP genes encode NRPSs with unusualCluster Boundaries
The boundaries of the lnm gene cluster were accurately architecture. In contrast to the modular NRPSs con-
sisting of multiple domains, lnmQ and lnmP encode adetermined through systematic inactivation by gene re-
placement of ORFs within the sequenced region. Inacti- discrete NRPS adenylation (A) [26] and PCP protein [27],
respectively. LnmQ is highly homologous to known ade-vation of genes (lnmA, lnmG, lnmI, lnmJ, and lnmZ)
within the lnm cluster abolished LNM production or re- nylation domains of modular NRPS, containing the
highly conserved 10 motifs (Figure 4A) [26]. LnmP dis-sulted in the production of new metabolites, whereas
inactivation of genes [orf(13), orf(11), orf(2), plays high sequence homology to both PCP domains
of modular NRPSs and discrete PCPs with the signatureorf(1), orf(1), orf(2), orf(3), orf(4), and orf(6)]
outside the lnm gene cluster had no effect on LNM motif of Gx(HD)S, in which the Ser residue can be post-
translationally modified by the covalent attachment ofproduction (Figure 3). These experiments led to the un-
ambiguous assignment of the boundaries for the lnm the 4-phosphopantetheine group [27, 28]. As judged
by their overlapping stop and start codons, lnmQ andgene cluster, which spans 61.3 kb of DNA and encom-
passes 27 ORFs designated lnmA to lnmZ (Figure 2 lnmP are most likely translationally coupled. Similar or-
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Figure 2. The Genetic Organization of the lnm Biosynthetic Gene Cluster
Proposed functions for individual ORFs are summarized in Table 1. The color coding legend indicates the types of genes identified with the
lnm cluster.
ganizations for both NRPS and PKS genes are known our knowledge, this is the first example where tandem
KS domains are identified within a PKS module. Whileand have been postulated to facilitate cotranslation of
the coupled genes to yield equimolar amounts of pro- both KSs (LnmI-KS3-1 and LnmI-KS3-2) show high ho-
mology to known KSs of PKS (Figure 5A) [30], the firstteins for optimal functional interactions, indicating that
LnmQ and LnmP are likely functionally related. KS domain contains a mutated catalytic triad of Cys-Ala-
His instead of the highly conserved Cys-His-His triadTo probe the role LnmQ and LnmP may play in LNM
production, we inactivated lnmQ by replacing it with a known to functional KSs [31–33]. Residing at the C termi-
nus of LnmI is a single KS domain (amino acid residuesmutant copy in which lnmQ was disrupted by the aa-
c(3)IV apramycin-resistance gene [25]. The resultant 3931–4437) that is characteristic for modular PKSs (Fig-
ure 5A). This KS presumably interacts with LnmJ in translnmQ mutant strain, SB3018, completely lost its ability
to produce LNM. Introduction of pBS3047, in which the to form a complete PKS module (module 4). Among
NRPSs and PKSs characterized to date, domains withinexpression of lnmQ is under the control of the constitu-
tive ErmE* promoter [25], into SB3018 restored LNM a module often reside on the same protein. An NRPS or
PKS module, such as module 4, that consists of domainsproduction to approximately 40% the wild-type S-140
strain. These results unambiguously established that residing on separate proteins is very rare, requiring pre-
cise protein-protein interaction between LnmI and LnmJlnmQ is essential for LNM biosynthesis (Figure 4B).
(Figure 1).
Genes Encoding Hybrid NRPS/PKS
The lnmI gene encodes a hybrid NRPS/PKS protein con- Genes Encoding PKS
The lnmJ gene encodes a giant protein of 7349 aminotaining domains characteristic of both NRPSs and PKSs.
The lnmI gene is essential for LNM biosynthesis since acid residues containing four KS, three ketoreductase
(KR), one dehydratatse (DH), one methyltransferaseinactivation of it completely abolished LNM production
[23]. Residing at the N terminus of LnmI is an NRPS (MT), six ACP, and one thioesterase (TE) domains char-
acteristic to PKSs, as well as a domain unknown tomodule (amino acid residues 1–1880) with the character-
istic condensation/cyclization (Cy)-Cy-A-PCP-oxidation PKSs (Figure 1). Inactivation of lnmJ completely abol-
ished LNM production, confirming that lnmJ is essential(Ox) domain organization [29]. We have previously dem-
onstrated that this module activates and loads L-Cys to for LNM biosynthesis [24]. The four KSs, like the three
KSs of LnmI, are highly homologous to typical KSs fromthe cognate PCP and proposed that it is responsible for
the biosynthesis of the thiazole moiety of LNM [23]. type I PKS modules (Figure 5A) and are characterized
by the highly conserved catalytic triad of Cys-His-HisFollowing the LnmI NRPS module is a PKS module (mod-
ule-3) (amino acid residues 1881–3930) with a novel [31–33]. The three KRs show significant homology to
known KR domains with the signature NADPH binding-keto synthase (KS)-KS-ketoreductase (KR)-acyl car-
rier protein (ACP) domain organization. To the best of site of GxGxxGxxxA [30, 34]. The DH domain has the
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Table 1. Deduced Functions of ORFs in the lnm Biosynthetic Gene Cluster
Gene Sizea Protein Homologb Proposed Function
orf(35) – orf(1) ORFs beyond the upstream boundary
lnmA 399 RapN (T30231, 42/62) Cytochrome P-450 hydroxylase
lnmB 78 RapM (T30230, 33/56) Ferredoxin
lnmC 115 - Unknown
lnmD 438 MupV (AAM12938, 23/37) Lactone hydrolase/decarboxylase
lnmE 307 - Unknown
lnmF 265 MupJ (AAM12923, 19/31) Enoyl CoA hydratase
lnmG 795 MmpIII (AAM12912, 46/62) Acyltransferase/oxidoreductase
lnmH 274 - Unknown
lnmI 4437 PedH (AY059471, 35/53) Hybrid NRPS/PKS
lnmJ 7349 PksM (C69679, 32/53) PKS
lnmK 319 TaD (CAB46503, 51/64) Unknown
lnmL 86 TaE (CAB46504, 41/57) Discrete ACP
lnmM 416 HmgS (BAB07795, 33/51) HMG-CoA synthase
lnmN 267 GrsT (P14686, 36/58) Type II TE
lnmO 227 BTR (Q08530, 27/45) Transcriptional activator
lnmP 82 AcpX (P43677, 43/56) Discrete PCP
lnmQ 516 NRPS8 (BAB69421, 41/51) Discrete NRPS A domain
lnmR 575 MoaD (T45539, 27/39) ABC transporter component
lnmS 287 AgaC (T45530, 29/42) ABC transporter component
lnmT 321 AgaB (T45531, 28/42) ABC transporter component
lnmU 513 OphA (C98307, 26/41) ABC transporter component
lnmV 120 - Unknown
lnmW 516 4-CL (B87644, 24/37) 4-Coumarate-CoA ligase
lnmX 243 SCF43.15c (CAB66204, 45/56) Unknown
lnmY 474 SCH42.31c (T35130, 36/52) Antibiotic efflux protein
lnmZ 400 McyG (S51594, 42/58) Cytochrome P-450 hydroxylase
lnmZ 134 - Unknown
orf(1) – orf(9) ORFs beyond the downstream boundary
a Numbers are in amino acids.
b Given in brackets are accession numbers and percentage identity/percentage similarity.
conserved active site of HxxxGxxxxP but is only 70% domain (Figure 1). Remarkably, these segments seem to
be highly conserved among all AT-less PKS modulesof the length of typical DH domains and lacks the
N-terminal 45 amino acid residues [30, 35]. The MT do- known to date [39, 40] and share well-defined bound-
aries (Figure 6A). They appear to be derived by multiplemain contains the three core motifs, LExGxAxA,
GxxxxxxD, and LxxPxG, of S-adenosylmethionine (Ado- deletions from a functional AT domain but cannot be
functional themselves due to the lack of the highly con-Met)-dependent MTs and is highly homologous to C-
MT domains of PKSs [36, 37]. The six ACPs exhibit served active site (GHSxG) and substrate binding
[A(FS)HS] motifs [30, 35, 41] (Figure 6B). While it remainshigh homology to known PKS ACPs, and all contain the
signature motif around the invariable 4-phosphopan- to be established if these regions play a role in LNM
biosynthesis, it is tempting to propose that they couldtetheine attachment site Ser residue (Figure 5B) [28,
30]. The extra domain at the C terminus of LnmJ is act as “docking sites” for the functional interaction be-
tween AT-less PKS enzymes and discrete ATs to consti-unprecedented in modular PKSs. It shows significant
sequence homology to various tyrosine phenol-lyases tute a functional megasynthetase. We therefore named
those segments as AT “docking” domains (Figures 1(TPLs), such as the one from Symbiobacterium ther-
mophilum (GenBank accession number A48380; 45% and 6).
The lnmG gene encodes a protein of 795 amino acidssimilarity and 27% identity) or Citrobacter freundii (ac-
cession number P31013; 41% similarity and 26% iden- that clearly can be divided into two distinct domains.
The N-terminal domain (amino acid residues 1–317)tity), but its role in LNM biosynthesis cannot be predicted
on the basis of sequence analysis. The TE domain is shows high sequence homology to AT domains of
known PKSs and contains the highly conserved activehighly homologous to other known TEs of type I PKS
characterized by the conserved active site motifs of site of GHSxG and substrate binding motif of AFHS that
is specific for malonyl-CoA [41]. The C-terminal domainGxSxG and GxH [38].
Strikingly, the six PKS modules (modules 3 to 8) en- (amino acid residues 318–795) exhibits low but recogniz-
able sequence homology to a family of oxidoreductases,coded by lnmI and lnmJ lack the cognate acyltransfer-
ase (AT) domain, which typically consists of approxi- such as MmpIII from Pseudomonas fluorescens (acces-
sion number AAM12912; 59% similarity and 44% iden-mately 320 amino acid residues and resides immediately
after the KS domain within the PKS module. Close exam- tity) or PedB from the symbiont bacterium of Paederus
fuscipes (accession number AAL27847; 57% similarityination of LnmI and LnmJ revealed instead a short seg-
ment of 90 to 110 amino acids immediately after every and 39% identity). LnmG is the only AT enzyme identified
within the lnm gene cluster, and inactivation of lnmGKS with the exception of the C-terminal LnmI-KS (mod-
ule 4), which seems to be the remnant of a functional AT completely abolished LNM production, confirming that
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Figure 3. Determination of the lnm Biosynthetic Gene Cluster Boundaries and HPLC Analysis of LNM Production by S. atroolivaceus Wild-
Type and Recombinant Strains
(A) Upstream boundary determination: I, LNM standard; II, wild-type S-140; III, SB3007 [orf(13)]; IV, SB3008 [orf(11)]; V, SB3009 [orf(2)];
VI, SB3010 [orf(1)]; VII, SB3011 (lnmA).
(B) Downstream boundary determination: I, wild-type S-140; II, SB3012 [orf(6)]; III, SB3013 [orf(4)]; IV, SB3014 [orf(3)]; V, SB3015
[orf(2)]; VI, SB3016 [orf(1)]; VII, SB3017 (lnmZ); filled circles, LNM; open triangles, an unknown metabolite whose production is
independent of LNM biosynthesis; filled diamond, a new metabolite accumulated by the lnmA mutant.
it is essential for LNM biosynthesis [24]. We have pre- gous to known cytochrome P-450 hydroxylases, such
as RapN from Streptomyces hygroscopicus (accessionviously characterized LnmG as a discrete AT enzyme
that loads the extender units in trans to the LnmI and number T30231; 42% identity and 62% similarity) and
MycG from Micromonospora griseorubida (accessionLnmJ AT-less PKS proteins for LNM biosynthesis [24].
The lnmL gene encodes a discrete ACP that contains number S51594; 42% identity and 58% similarity). They
both contain the characteristic heme binding motif ofthe signature motif around the invariable 4-phospho-
pantethein attachment site Ser residue (Figure 5B) [28, FGHGAHxCLG [42]. Translationally coupled with lnmA
is lnmB, encoding a ferredoxin that would be required30]. The deduced gene product of lnmM shows high
sequence homology to both ketoacyl synthases, such for the catalytic cycle of cytochrome P-450 enzymes.
The fact that only one ferredoxin-encoding gene is iden-as TaF from Myxococcus xanthus (accession number
CAB46505; 76% similarity and 62% identity) or MupH tified within the lnm gene cluster suggests that the two
LnmA and LnmZ cytochrome P-450 enzymes may sharefrom Pseudomonas fluorescens (accession number
AAM12922; 62% similarity and 44% identity), and the the same electron-transferring partner. Inspection of the
LNM structure suggests at least three oxidation steps3-hydroxy-3-methylglutaryl (HMG)-CoA synthase family
of enzymes, such as HmgS from Streptomyces sp. in LNM biosynthesis (hydroxylation at C-8 and C-4 and
oxidation at S-1), and LnmA, LnmB, and LnmZ couldCL190 (accession number BAB07795; 51% similarity
and 33% identity) or MvaS from Enterococcus faecium serve as candidates for these enzyme activities (Figure
1). Indeed, preliminary analysis of the new metabolite(accession number AAG02443; 49% similarity and 31%
identity). While the molecular origin of the 1,3-dioxo- accumulated by lnmA mutant (Figure 3A, VII) by high-
resolution mass spectrometry yielded (MH) and1,2-dithiolane moiety remains to be established, LnmL
and LnmM could play a role in fusing this moiety to the (MNa) ions at m/z 465.156 and 487.138, consistent
with the molecular formula C22H28N2O5S2 [calculatedLNM macrolactam ring (Figure 1).
465.152 for (MH) and 487.134 for (MNa)]. In con-
trast, high-resolution mass spectrometry analysis of theGenes Encoding Tailoring Enzymes
Flanking the boundaries of the lnm gene cluster are corresponding LNM degradation product isolated from
the S-140 wild-type strain yielded (MH) and (MNa)lnmA and lnmZ, the deduced gene products of which
share significant sequence homology with each other ions at m/z  497.143 and 519.125, consistent with the
molecular formula C22H28N2O7S2 [calculated 497.142 for(40% identity and 56% similarity) and are highly homolo-
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Figure 4. Functional Analysis of lnmQ in LNM
Biosynthesis
(A) Conserved motifs of LnmQ in comparison
with other NRPS A domains. The conserved
amino acids are in bold. LnmQ homologs (ac-
cession numbers in parentheses) are as fol-
lows: Ave-NRPS8 (BAB690421) from Strepto-
myces avermitilis, GrsA (AAB22346) from
Bacillus subtilis, CssA (S41309) from Toly-
pocladium niveum, and HTS1 (Q01886) from
Cochliobolus carbonum.
(B) HPLC analysis of LNM production by S.
atroolivaceus wild-type and recombinant
strains. I, LNM standard; II, wild-type S-140;
III, SB3018 (lnmQ); IV, SB3020 (SB3018 har-
boring the lnmQ overexpression plasmid
pBS3047). Filled circles, LNM; open triangles,
an unknown metabolite whose production is
independent of LNM biosynthesis.
(C) The substrate selectivity-conferring code
of LnmQ in comparison with codes for the
D-Ala-specific A domains of CssA-A1 and
HTS1-A3. The same and similar residues are
highlighted in bold.
(MH) and 519.124 for (MNa)] [60]. The molecular tity and 58% similarity) or McyT from Planktothrix agard-
hii (accession number CAD29792; 41% identity and 58%weight difference of 32 between these two compounds
(i.e., 2 H atoms versus 2 OH groups) agrees perfectly similarity), and is characterized by the conserved active
site motifs of GxSxG and GxH [38]. Type II TEs havewith the predicted function of LnmA as a cytochrome
P-450 hydroxylase and suggests that inactivation of been identified from both polyketide and nonribosomal
peptide biosynthetic gene clusters. It has been generallylnmA apparently prevents hydroxylation of the corre-
sponding LNM biosynthetic intermediate at both C-8 accepted that type II TEs play an “editing” role by remov-
ing misprimed ACPs (for PKS) or PCPs (for NRPS) toand C-4 positions.
The lnmD gene encodes a protein exhibiting low se- ensure the catalytic efficiency and fidelity in polyketide
[43, 44] or peptide biosynthesis [45], respectively. Thequence homology to several 3-oxoadipate enol-lactone
hydrolase/4-carboxymuconolactone decarboxylases, such identification of the LnmN type II TE from the lnm gene
cluster provides an excellent opportunity to investigateas MupV from Pseudomonas fluorescens (accession
number AAM12938; 23% identity and 37% similarity). if LnmN plays a similar editing role in a mechanistic
analogy to type II TEs for PKSs or NRPSs, but with aThe lnmF gene product resembles known enoyl CoA
hydratases, such as MupJ from Pseudomonas fluo- relaxed substrate specificity by removing misprimed
acyl intermediates from both the ACP and PCP domainsrescens (accession number AAM12923; 19% identity
and 31% similarity). The deduced gene product of lnmW of the LNM hybrid NRPS-PKS megasynthetase.
shows high sequence homology to a family of 4-coumar-
ate-CoA ligases, such as the one from Caulobacter cres- Regulatory, Resistance, and Other Genes
Encoding Proteins of Unknown Functioncentus (accession number B87644; 24% identity and
37% similarity). It is not clear what role these proteins The lnmO gene is the only apparent regulatory gene
identified within the lnm cluster. The deduced genecould play in LNM biosynthesis.
The deduced gene product of lnmN is highly homolo- product of lnmO is a 25.7 kDa protein that belongs to
a family of transcriptional activators, such as DNR fromgous to other known type II TEs, such as GrsT from
Bacillus subtilis (accession number P14686; 36% iden- Alcaligenes faecalis (accession number BAA90776; 27%
Leinamycin Biosynthetic Gene Cluster
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41% similarity), respectively, but share no sequence ho-
mology with each other. LnmU exhibits significant se-
quence homology to a family of periplasmic oligopep-
tide binding proteins, such as OphA from Agrobacterium
tumefaciens (accession number C98307; 26% identity
and 41% similarity) or DppA from Brucella melitensis
(accession number P23847; 22% identity and 37% simi-
larity). Together, LnmR, LnmS, LnmT, and LnmU could
be envisaged to constitute an ATP binding cassette
transporter complex [46] for active transport of LNM out
of producing cells. LnmY displays significant sequence
homology to various antibiotic efflux proteins, such as
SCH42.31c from Streptomyces coelicolor (3)2 (acces-
sion number T35130; 36% identity and 52% similarity) or
McT from Streptomyces lavendulae (accession number
AAD32747; 32% identity and 52% similarity), which
could potentially provide an alternative resistance mecha-
nism to S. atroolivaceus S-140 by passively dispersing
LNM across the cell membrane.
The remaining genes, lnmC, lnmE, lnmH, lnmK, lnmV,
lnmX, and lnmZ, identified within the lnm gene cluster
encode proteins that either show no significant se-
quence homology to any proteins in the databases or
resemble proteins with unknown functions. While it re-
mains to be established what role these proteins could
play in LNM biosynthesis, inactivation of each of them
Figure 5. Sequence Analysis of the LnmIJ PKSs by gene replacement completely abolished LNM pro-
(A) Phylogenetic analysis of the LnmI and LnmJ KSs and their homo- duction, confirming unambiguously that they are essen-
logs from other polyketide and hybrid peptide-polyketide biosyn- tial for LNM biosynthesis (G.-L.T., B. Yun, Y.-Q.C., and
thetic gene clusters. KS-containing homologs (natural product/ B.S., unpublished data).
accession numbers in parentheses) are as follows: BlmVIII (bleomy-
cin/AF210249), EposB (epothilone/AF217189), MtaD (myxothiazole/
AF188287), McyC (microcystin/AF183408), NosB (nostopeptolide/
DiscussionAF204805), HMWP1 (yersiniabactin/af091251), PksK and PksP (un-
known compound/AL009126), TA1 (TA antibiotic/AJ006977), DEBS1
(erythromycin/Q03131), PikAIV (pikromycin/AF079138), AveA3 (av- The LNM Biosynthetic Gene Cluster Consisting
ermectin/AB032367), and RifA (rifamycin/AF040570). of 27 Genes
(B) Compilation of the core sequences of LnmI and LnmJ ACP do- Given the unprecedented structure of LNM, we rea-
mains as well as the discrete LnmL ACP. The invariant Ser and other
soned that knowing the precise boundaries of the lnmconserved residues are in bold.
gene cluster should greatly facilitate our effort to postu-
late a model for LNM biosynthesis and to carry out
functional analysis of the lnm gene cluster. Two roundsidentity and 47% similarity) or BTR from Bordetella per-
tussis (accession number Q08530; 27% identity and of gene inactivation were carried out, identifying the
upstream boundary to be between orf(1) and lnmA.45% similarity). Inactivation of lnmO by gene replace-
ment completely abolished LNM production, confirming On the basis of sequence analysis, we initially predicted
that the upstream boundary of the lnm cluster wouldits involvement in LNM production (G.-L.T., B. Yun,
Y.-Q.C., and B.S., unpublished data). start from orf(2) that encodes an NRPS module. To
test this hypothesis, we chose to inactivate orf(2) asAt least five genes, lnmR, lnmS, lnmT, lnmU, and lnmY,
could be identified within the lnm gene cluster whose a target within the lnm cluster and orf(11) and orf (13),
which encode an NRPS module and a discrete NRPSdeduced gene products could confer LNM resistance
to S. atroolivaceus S-140. LnmR shows high sequence condensation (C) enzyme, respectively, as targets be-
yond the predicted upstream boundary. They were re-homology to various ATP hydrolases, such as MoaD
from Agrobacterium tumefaciens (accession number placed, respectively, with a mutant copy in which the
target ORF was substituted with the apramycin-resis-T45539; 27% identity and 39% similarity) or YliA from
E. coli (accession number P75769; 27% identity and tance gene, aac(3)IV [27]. To our surprise, the resultant
S. atroolivaceus SB3007 [orf(13)], SB3008 [orf(11)],39% similarity). Both LnmS and LnmT show significant
sequence homology to transmembrane proteins, such and SB3009 [orf(2)] mutant strains exhibited the
same phenotype as the wild-type S-140 strain and pro-as AgaC from Agrobacterium tumefaciens (accession
number T45530; 29% identity and 42% similarity) and duced LNM at a level comparable to the S-140 strain
from HPLC analysis (Figure 3A, II versus III, IV, or V).DppC from Brucella melitensis (accession number
AF3306; 28% identity and 40% similarity) or AgaB from These results suggested that orf(2), orf(11), and
orf(13) are all outside of the lnm gene cluster. We nextAgrobacterium tumefaciens (accession number T45531;
28% identity and 42% similarity) and DppB from Brucella inactivated orf(1), which also encodes a discrete NRPS
C enzyme, and lnmA, which encodes a cytochromemelitensis (accession number AF3535; 27% identity and
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Figure 6. Sequence Analysis of AT-less PKSs
(A) Compilation of deduced amino acid sequences of AT docking domains from LnmI and LnmJ and other AT-less PKSs. PedF and PedH are
AT-less PKSs from the pederin biosynthetic gene cluster (accession number AY059471), and MmpA, MmpB, and MmpD are AT-less PKSs
from the mupirocin biosynthetic gene cluster (accession number AF318063). The conserved amino acid residues are highlighted in bold.
(B) Diagram of homologous regions between the AT docking domain and the functional LnmG-AT domain. Regions containing the conserved
active site of GHSxG and substrate binding motif of AFHS for a functional AT domain are absent in the AT docking domain.
P-450 hydroxylase, leading to the isolation of the S. essential for LNM biosynthesis (Figure 3A, II versus VI
or VII; the abolishment of LNM production in VII wasatroolivaceus SB3010 [orf(1)] and SB3011 (lnmA)
mutant strains, respectively. The SB3010 strain pro- confirmed by LC-mass spectrometric analysis). Taken
together, these results allowed the assignment of theduced LNM in a level comparable to the wild-type S-140
strain, indicative that inactivation of orf(1) has no ap- upstream boundary of the lnm gene cluster to be be-
tween orf(1) and lnmA (Figure 2).parent effect on LNM production. In contrast, the
SB3011 strain completely lost its ability to produce LNM The downstream boundary of the lnm gene cluster
was defined by the same strategy to be between lnmZand instead accumulated new metabolites that were not
detected in the S-140 strain, suggesting that lnmA is and orf(1). Initial sequence analysis failed to predict a
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putative downstream boundary due to its complex genetic thase) within the lnm gene cluster provided a clue that
allowed us to speculate about how the 1,3-dioxo-1,2-organization. Within the sequenced downstream region,
the genes appear to be organized as multiple transcrip- dithiolane moiety could be fused to 1 in LNM biosynthe-
sis. We propose that LnmM, in a mechanistic analogytional units, as evidenced by the frequent change of
their transcriptional directions, and many of the ORFs to HMG-CoA synthase, could catalyze the condensation
of methylmalonyl CoA at the -keto group of 1 (or itslack homology to proteins of known function in the data-
bases, further complicating sequence-based functional linear acyl-S-ACP precursor before cyclization) to afford
intermediate 2. The Similar reactions have been pro-assignment. Therefore, a series of gene replacement
experiments were carried out to inactivate lnmZ, posed for the biosynthesis of several polyketides with
alkyl side chains [40, 48]. Methylmalonyl CoA could alsoorf(1), orf(2), orf(3), orf(4), and orf(6), which
were predicted to encode proteins of unknown function be presented to LnmM in its ACP-activated form of
methylmalonyl-S-LnmL, the formation of which could[LnmZ, ORF(1), ORF(3)], a type II thioesterase
[ORF(2)],aTetR-familytranscriptionalregulator[ORF(4)], be catalyzed by LnmG. Tethering metabolites of primary
metabolism to carrier proteins such as ACP and PCPand a putative hydrolase/lactonase [ORF(6)], respec-
tively. The lnmZ mutant strain, SB3017, essentially as a general strategy to sequester and thus divert them
to secondary metabolism has been proposed previouslylost its ability to produce LNM. It instead accumulated
new metabolites that were not detected from the S-140 [49, 50]. Further modifications of 2, via 3 as a possible
intermediate, by other tailoring enzymes could finallystrain, suggesting that lnmZ is critical for LNM biosyn-
thesis (Figure 3B, I versus VII; the trace amount of LNM afford LNM. LnmA (P-450 hydroxylase), LnmB (ferre-
doxin), and LnmZ (P-450 hydroxylase) could serve asproduced in VII was confirmed by LC-mass spectromet-
ric analysis). In contrast, the other mutant strains, excellent candidates to catalyze the C-8 and C-4 hy-
droxylation and S-1 oxidation, respectively, thus con-SB3016 [orf(1)], SB3015 [orf(2)], SB3014
[orf(3)], SB3013 [orf(4)], and SB3012 [orf(6)], verting 3 to LNM (Figure 1). While the order of many of
these steps has to be determined experimentally, theexhibited the same phenotype as and produced LNM
in a level comparable to the S-140 strain (Figure 3B), proposed model for LNM biosynthesis is consistent with
the genes and the functions of their deduced gene prod-indicating that they are all outside of the lnm gene cluster
(Figure 3B, I versus II, III, IV, V, or VI). Taken together, ucts identified within the lnm cluster.
these results showed the downstream boundary of the
lnm gene cluster to be at the end of lnmZ (Figure 2).
Unprecedented Architectural Complexity of the
LNM Hybrid NRPS/PKS Megasynthetase
Initiation and Peptide Biosynthesis by NRPSModel for LNM Biosynthesis
Precise determination of the lnm gene cluster bound- According to the LNM structure, the current paradigm
for hybrid peptide-polyketide biosynthesis would pre-aries allowed us to propose a model for LNM biosynthe-
sis on the basis of the genes within the cluster and their dict two NRPS modules for the biosynthesis of the pep-
tide moiety of LNM [20, 29, 47]. An NRPS loading mod-deduced functions (Figure 1). According to the hybrid
NRPS-PKS assembly-line enzymology [20, 29, 47], LNM ule, presumably having an A-PCP-epimerase (E) domain
organization, would select and activate the readily avail-biosynthesis could be envisaged to begin at the loading
NRPS module consisting of LnmQ and LnmP. LnmQ able L-Ala. Upon loading of L-Ala to the cognate PCP to
form an L-Ala-S-PCP intermediate, the E domain wouldselects, activates, and loads a D-Ala to LnmP to initiate
LNM biosynthesis. The LnmI NRPS module then selects, convert L-Ala into D-Ala to set the stage for chain elon-
gation. Alternatively, the loading module could be ofactivates, and loads a L-Cys to its cognate PCP and
catalyzes the condensation between the aligned D-Ala- A-PCP organization, indicative of direct activation and
loading of D-Ala to the cognate PCP to initiate LNMS-PCP and L-Cys-S-PCP. Subsequent cyclization and
oxidation yield the thiazonyl-S-PCP intermediate. At biosynthesis. Sequence analysis of the lnm gene clus-
ter, however, failed to identify any NRPS with eitherthis point, the growing peptidyl-S-PCP intermediate is
switched from the NRPS to the PKS assembly-line bio- A-PCP-E or A-PCP organization. Instead, we only identi-
fied LnmQ and LnmP, a pair of discrete NRPS A andsynthetic machinery. The discrete LnmG AT provides
the missing AT activity in trans to LnmI and LnmJ and PCP proteins, within the lnm cluster (Figure 2).
The proposal that LnmQ and LnmP constitute theloads the malonyl CoA extender units to all ACP domains
of the six LnmI and LnmJ PKS modules. The docking loading module to initiate LNM biosynthesis is consis-
tent with the fact that lnmQ and lnmP are translationallydomains within the AT-less PKS modules could facilitate
the interaction between LnmG and LnmI and LnmJ. Se- coupled, ensuring that LnmQ and LnmP are produced
in equimolar amounts for optimal interactions. This pro-quential elongations of the thiazonyl-S-PCP intermedi-
ate by the LnmI and LnmJ PKS modules complete the posal also agrees well with the D-Ala specificity of LnmQ
predicted according to the amino acid specificity-con-biosynthesis of the LNM hybrid peptide-polyketide car-
bon backbone. The full-length acyl-S-ACP intermediate ferring codes of the A domain [51, 52]. Although a D-Ala-
specific A domain of bacterial origin was not knownis then released and cyclized by the TE domain of LnmJ
to yield a macrolactam intermediate such as 1 (Figure 1). prior to this work, two D-Ala-specific A domains of fungal
origin, CssA-A1 for cyclosporin biosynthesis from Toly-The unprecedented structure of the 1,3-dioxo-1,2-
dithiolane moiety of LNM has precluded us from pre- pocladium niveum [53] and HTS1-A3 for HC-toxin bio-
synthesis from Cochliobolus carbonum [54], have beendicting its biosynthetic pathway a priori. However, the
identification of LnmL (ACP) and LnmM (HMG-CoA syn- characterized. Moderate conservation of the amino acid
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specificity-conferring codes between LnmQ and the two sent a novel mechanism to facilitate the transition from
peptide to polyketide biosynthesis (Figure 1, module 3).known D-Ala-specific A domains is apparent (Figure 4C),
Elongation and Termination by PKSsupporting the functional assignment of LnmQ and
The LnmI PKS-bound growing intermediate continuesLnmP to constitute the loading module that directly acti-
to be elongated by the five PKS modules (modules 4vates and incorporates D-Ala into LNM biosynthesis.
to 8) on LnmJ, furnishing the full-length LNM peptide-LnmQ and LnmP therefore represent a novel architec-
polyketide backbone (Figure 1). While the deduced LnmIture for an NRPS loading module consisting of discrete
and LnmJ PKS functions are consistent with what wouldA and PCP proteins (Figure 1, module 1).
be required for the biosynthesis of the polyketide moietyFollowing the priming of LnmP with D-Ala by LnmQ,
of LNM from the acyl CoA precursors, several notablethe second NRPS module (module 2), residing at the
features of the LnmI and LnmJ PKS are unprecedented.N terminus of LnmI with a Cy-Cy-A-PCP-Ox domain
Most strikingly, none of the six PKS modules of LnmIorganization, elongates the D-Ala-S-PCP with the cog-
and LnmJ contain the cognate AT domain. We havenate L-Cys-S-PCP and cyclizes and oxidizes the resul-
previously named LnmI and LnmJ as AT-less PKSs andtant D-alaninyl-L-cysteinyl-S-PCP to yield the thiazonyl-
demonstrated that the missing AT activity is providedS-PCP intermediate. The LnmI NRPS module is charac-
by the discrete LnmG AT enzyme that acts iteratively interized by tandem Cy domains, which are rare and have
trans to load the malonyl CoA extender units to ACPonly been previously identified for the vibriobactin gene
domains of the six PKS modules for LNM biosynthesiscluster from Vibrio cholerae [55]. In a mechanistic anal-
[24]. Intriguingly, the short segments sandwiched be-ogy to VibF, we propose that the second Cy domain is
tween KS and the downstream domains within an AT-responsible for condensation, yielding the D-alaninyl-
less PKS module appear to be conserved among all AT-L-cysteinyl-S-PCP intermediate that is subsequently cy-
less PKSs known to date (Figure 6). We now proposeclized by the first Cy domain to afford the D-alaninylthia-
that they may serve as indigenous docking sites andzolinyl-S-PCP intermediate. Oxidation of the latter by
facilitate protein-protein interaction between AT-lessthe Ox domain then yields the thiazonyl-S-PCP interme-
PKSs and discrete ATs to constitute a functional mega-diate, setting the stage for the elongation steps to switch
synthetase (Figure 1, module 3 to module 8).from the NRPS to the PKS assembly-line machinery
Other novel features of the LnmG, LnmI, and LnmJ(Figure 1, module 2).
PKS megasynthetase include domain redundancy, do-NRPS-to-PKS Transition
main misposition, having a domain missing, or having
A fundamental question for hybrid peptide-polyketide
an extra domain. As examples, (1) PKS modules 3 and
biosynthesis is how a hybrid NRPS-PKS controls the 6 each lack a DH domain, and PKS module 7 lacks both
transition between the NRPS and PKS biosynthetic ma- DH and ER domains. (2) PKS module 6 has two ACP
chinery [20, 47]. We have previously shown that the KS domains flanking an MT domain, although the presence
domains from PKS modules at the hybrid NRPS/PKS of the MT domain in PKS module 6 is consistent with
interface are unique in comparison with those from nor- the malonyl-CoA-specificity of LnmG, indicating that the
mal PKS modules. While all KSs contain the highly con- methyl group at C-6 is of AdoMet origin. (3) Extra do-
served Cys-His-His catalytic triad, those from PKS mod- mains unprecedented in PKS are found between PKS
ules at the hybrid NRPS/PKS interface fall into a distinct module 8 and the TE and at the C terminus of LnmG,
subfamily in a phylogenetic analysis. The latter observa- respectively (Figure 1). It should be pointed out that the
tion led to the speculation that PKS modules at the definition of these features as atypical is very subjective,
hybrid NRPS/PKS interface might have evolved a unique based on the so-called “colinearity rule” for modular
KS domain to facilitate the transition from peptide to PKSs [20, 29, 30, 47]. However, numerous exceptions
polyketide biosynthesis [20]. Surprisingly, the LnmI PKS to the latter have been observed recently, and PKSs
module at the hybrid NRPS/PKS interface (Figure 1, with atypical domain and modular organizations may be
module 2/module 3) is characterized by an unprece- much more common than currently thought [56]. While
dented tandem KS architecture, but neither of the KS the details of how the LNM hybrid NRPS-PKS megasyn-
domains fall into the hybrid NRPS/PKS subfamily of KSs thetase catalyzes LNM biosynthesis from the amino acid
(Figure 5A). Instead, they are more closely related to and short carboxylic acid precursors have to wait for
KSs from normal PKS modules, with the exception that future in vivo and in vitro experimentation, the current
the first KS contains a mutated catalytic triad of Cys- analysis provides a working model that can be used to
Ala-His. Since the His-His residues are essential for mal- formulate research hypotheses and to design experi-
onyl-S-ACP decarboxylation to generate the corre- ments to further these investigations. Regardless of
sponding carbon anion, and the Cys residue catalyzes these unusual features, LNM biosynthesis appears to be
condensation between the resultant carbon anion and terminated by a mechanism common to both polyketide
the acyl-S-KS to form a C-C bond [30–33], the first KS and peptide biosynthesis [29, 30, 38]. The LnmJ TE off-
domain alone cannot be sufficient to catalyze the entire loads the full-length hybrid peptide-polyketide interme-
chain elongation step. We propose that the first KS do- diate from the LNM hybrid NRPS-PKS megasynthetase
main catalyzes the transfer of the growing peptide inter- and cyclizes it into the macrolactam intermediate 1.
mediate of peptidyl-S-PCP from the upstream NRPS Post-NRPS and -PKS modifications by the tailoring en-
module (module 2) to its Cys residue, and the second zymes finally afford LNM (Figure 1).
KS domain catalyzes the decarboxylative condensation
between the resulting peptidyl-S-KS and the cognate Significance
malonyl-S-ACP (module 3) to complete the elongation
step. The LnmI hybrid NRPS/PKS protein with tandem A 135,638 bp DNA region that encompasses the bio-
synthetic gene cluster for the antitumor antibiotic LNMKS domains in the PKS module therefore might repre-
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tion of exconjugants, and confirmation of homologous recombina-was sequenced from S. atroolivaceus S-140. System-
tion by Southern hybridization were performed as described pre-atic inactivation of ORFs within this region resulted
viously [23, 24].in the precise determination of the lnm gene cluster
boundaries. Bioinformatic and genetic analysis of the Inactivation by Gene Replacement
lnm cluster allowed us to propose a model for LNM To inactivate orf(13), XbaI and HindIII sites were introduced into
orf(13) by PCR using the following two pairs of primers: 5-TAAbiosynthesis. The assembly of the hybrid peptide-poly-
TACGACTCACTATAGGGCGA-3/5-GCTCTAGACTCCTTCGACCTketide backbone of LNM from the amino acid and car-
GTTCGACC-3 (the XbaI site is underlined) and 5-GGAGAAGCTTboxylic acid precursors is proposed to be catalyzed
GACGAAGAAGCCGATGAGC-3/5-GACAGCGATGACCGAGAC-3
by the LNM hybrid NRPS-PKS megasynthetase with an (the HindIII site is underlined). A 1.5 kb HindIII-XbaI fragment con-
unprecedented architectural complexity, consisting of taining the aac(3)IV apramycin-resistance gene was inserted into
discrete and modular NRPSs, AT-less PKSs, and PKS the engineered XbaI and HindIII sites, resulting in the replacement
of a 326 bp internal fragment of orf(13) with aac(3)IV. The mutatedmodules with unusual domain organizations. Modifi-
orf(13) was then moved as a 3.7 kb EcoRI-PstI fragment into thecations of the nascent hybrid peptide-polyketide inter-
same sites of pSET151 to yield pBS3034. To inactivate orf(11), anmediate to form LNM are proposed to involve tailoring internal 12 bp NcoI-NotI fragment was replaced with a 1.5 kb NcoI-
enzymes that catalyze novel chemistry for the intro- NotI fragment containing aac(3)IV, and the mutated orf(11) was
duction of an alkyl branch into the polyketide back- cloned as a 6.0 kb XbaI-HindIII fragment into the same sites of
pSET151 to yield pBS3035. To inactivate orf(2), an internal 695 bpbone and the formation of the 1,3-dioxo-1,2-dithiolane
BglII-BglII fragment was replaced with a 1.5 kb BglII-BamHI frag-moiety. These findings set the stage to investigate
ment containing aac(3)IV, and the mutated orf(2) was transferredthe molecular basis of LNM biosynthesis and to apply
as a 9.3 kb EcoRI fragment into the same site of pSET151 to afford
combinatorial biosynthesis methods to the LNM bio- pBS3036. To inactivate orf(1), an internal 1263 bp NcoI-NotI frag-
synthetic machinery to increase structural diversity ment was replaced with a 1.5 kb NcoI-NotI fragment containing
aac(3)IV, and the mutated orf(1) was cloned as a 4.7 kb SphI-for anticancer drug discovery.
EcoRI fragment into the same sites of pSET151 to furnish pBS3037.Studies on peptide, polyketide, and hybrid peptide-
To inactivate lnmA, an internal 428 bp XhoI-PvuII fragment waspolyketide biosynthesis in the past decade have bene-
replaced with a 1.5 kb XhoI-PvuII fragment containing aac(3)IV, and
fited greatly from the “colinearity rule” for most of the the mutated lnmA was moved as a 2.8 kb HindIII-EcoRI fragment
modular PKSs, NRPSs, and hybrid NRPS-PKSs known into the same sites of pSET151 to yield pBS3038.
To inactivate orf(6), a BglII site was introduced into orf(6) byto date. Innovations in methodologies for cloning bio-
PCR using the following pairs of primers: 5-GGCTACGCATGCTATsynthetic gene clusters and advances in technologies
CTCGCCGAGAAGG-3/5-GGTGAGATCTTGCGAGTTGGTGCGTG-for DNA sequencing and bioinformatic analysis have
3 and 5-TCGCAAGATCTCACCCATGCTTCAGTCC-3/5-GAAGAA
facilitated the unveiling of NRPSs, PKSs, and hybrid TTCTGATGAAAAGACCCTGTG-3 (the BglII site is underlined). A
NRPS-PKSs with novel mechanisms and structures. 1.5 kb BglII-BamHI fragment containing acc(3)IV was then inserted
into the engineered BglII site, and the mutated orf(6) was clonedThe LNM hybrid NRPS-PKS megasynthetase is excep-
as a 3.4 kb SphI-EcoRI fragment into the same sites of pSET151 totional in this regard for its unprecedented architectural
afford pBS3039. To inactivate orf(4), an internal 243 bp NotI-AatIIcomplexity. These findings underscore once again na-
fragment was replaced with a 1.5 kb NotI-AatII fragment containing
ture’s versatility in evolving complex pathways for nat- acc(3)IV, and the mutated orf(4) was moved as a 3.0 kb SphI-
ural product biosynthesis. They also provide new op- EcoRI fragment into the same sites of pSET151 to yield pBS3040.
portunities to study the fundamental enzymology of To inactivate orf(3), a 1.5 kb KpnI-BamHI fragment containing
acc(3)IV was inserted into the internal KpnI site, and the mutatedand to develop new combinatorial biosynthesis meth-
orf(3) was cloned as a 3.2 kb SphI fragment into the same site ofods for the NRPS, PKS, or hybrid NRPS-PKS biosyn-
pSET151 to afford pBS3041. To inactivate orf(2), an internal 84thetic machinery. bp NcoI-KpnI fragment was replaced with a 1.5 kb BamHI-KpnI
fragment containing acc(3)IV, and the mutated orf(2) was trans-
ferred as a 3.4 kb HindIII-XbaI fragment into the same sites ofExperimental Procedures
SET151 to furnish pBS3042. To inactivate orf(1), a 1.5 kb NcoI
fragment containing acc(3)IV was inserted into the internal NcoI site,Strains, Plasmids, Chemicals, Biochemicals,
and the mutated orf(1) was cloned as a 3.8 kb PstI-EcoRI fragmentand LNM Production and Analysis
into the same sites of pSET151 to give pBS3043. To inactivate lnmZ,The wild-type S. atroolivaceus S-140 strain [23, 24], E. coli S17-1
an internal 84 bp NotI-BamHI fragment was replaced with a 1.5 kb[57], plasmids pSET151 [57] and pBS3031 [24], the aac(3)IV apra-
NotI-BamHI fragment containing acc(3)IV, and the mutated lnmZmycin-resistance gene cassette [25], and the ErmE* promoter [25]
was transferred as a 4.2 kb SphI-EcoRI fragment into the same siteswere described previously. Common chemicals and biochemicals
of pSET151 to form pBS3044.were from commercial sources. LNM production and isolation from
To inactivate lnmQ, a 1.5 kb KpnI-XbaI fragment containg aac(3)IVboth the wild-type and recombinant S. atroolivaceus strains and
was inserted into the internal KpnI-XbaI sites, and the mutated lnmQLNM analysis by HPLC and mass spectrometry were carried out as
was cloned as a 4.8 kb BamHI-HindIII fragment into the same sitespreviously reported [23, 24].
of pSET151 to yield pBS3045.
Constructs pBS3034 through pBS3045 were each introduced into
DNA Sequencing, Analysis, and Manipulation S. atroolivaceous S-140 by conjugation. The desired double-cross-
The lnm gene cluster was previously localized to five overlapping over homologous recombinant events were selected for using the
cosmids, pBS3004, pBS3005, pBS3006, pBS3007, and pBS3008 apramycin-resistant and thiostrepton-sensitive phenotype, leading
[24]. DNA sequencing by a shotgun method of the first four cosmids to the isolation of mutant strains SB3007 [orf(13)], SB3008
yielded a 135,638 bp contiguous DNA sequence. Bioinformatic anal- [orf(11)], SB3009 [orf(2)], SB3010 [orf(1)], SB3011 (lnmA),
yses of DNA and protein sequence were carried out with the Genet- SB3012 [orf(6)], SB3013 [orf(4)], SB3014 [orf(3)], SB3015
ics Computer Group (GCG) program (Madison, WI) [58] or the Clustal [orf(2)], SB3016 [orf(1)], SB3017 (lnmZ), and SB3018
W program [59]. Functional assignments were made by utilization (lnmQ), respectively. The genotypes of these mutants were con-
of the BLAST server at the National Center for Biotechnology Infor- firmed by Southern analysis.
mation (Bethesda, MD) and comparison of the deduced gene prod-
ucts with proteins of known functions in the database. General pro- Complementation of the lnmQ mutant
cedures for genetic manipulations in E. coli and in S. atroolivaceus, To construct the lnmQ expression plasmid, a 450 bp EcoRI-BamHI
fragment harboring the ErmE* promoter and a 2.7 kb BamHI-SphIthe conjugation between E. coli S17-1 and S. atroolivaceus, selec-
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fragment containing the intact lnmQ were cloned into the EcoRI- 13. Fukuyama, T., and Kanda, Y. (1994). Total synthesis of ()-
leinamycin. J. Synth. Org. Chem. Jpn. 52, 888–899.SphI sites of pBS3031 to yield pBS3047. The expression of lnmQ
in pBS3047 is under the control of the ErmE* promoter. pBS3047 14. Kanda, Y., and Fukuyama, T. (1993). Total synthesis of ()-
leinamycin. J. Am. Chem. Soc. 115, 8451–8452.was introduced into the lnmQ mutant strain of S. atroolivaceus
SB3018 by conjugation. Selection for apramycin and thiostrepton 15. Kanda, Y., Ashizawa, T., Kawashima, K., Ikeda, S.-I., and Ta-
maoki, T. (2003). Synthesis and antitumor activity of novel C-8resistance resulted in the isolation of the recombinant strain SB3020
that harbors pBS3047. The S. atroolivaceus SB3020 strain was cul- ester derivatives of leinamycin. Bioorg. Med. Chem. Lett. 13,
455–458.tured and analyzed by HPLC and mass spectrometry for LNM pro-
duction with the S-140 wild-type strain as a control. 16. Behroozi, S.I., Kim, W., and Gates, K.S. (1995). Reaction of
N-propanethiol with 3H–1,2-benzodithiol-3-one 1-oxide and
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